Sms Pharmaceuticals Ltd — Quarterly Results & Earnings

₹374.85

-5.18%

Profit Growth YoY76.30%Latest quarter

Sales Growth YoY23.22%Latest quarter

Sales CAGR 5Y13.70%5 year compound

Profit CAGR 5Y15.88%5 year compound

📋

Quarterly Performance

YoY Profit Growth+76.30%

🔥 Exceptional growth

YoY Sales Growth+23.22%

🔥 Exceptional growth

OPM 5Y Average

Operating profit margin

17.68%

EPS Growth 5Y

14.83%

Interest Coverage

Higher = safer debt servicing

6.25

ROE

11.00%

ROCE

12.19%

💡

Growth Analysis

Sms Pharmaceuticals Ltd reported YoY profit growth of 76.30% and revenue growth of 23.22% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 13.70% and profits at 15.88% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Sms Pharmaceuticals Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.